Tom 12, Nr 4 (2016)
Artykuł przeglądowy
Opublikowany online: 2017-02-14
Wyświetlenia strony
4021
Wyświetlenia/pobrania artykułu
15778
Encefalopatia Hashimoto – patogeneza, obraz kliniczny i leczenie
Pol. Przegl. Neurol 2016;12(4):206-210.
Streszczenie
Encefalopatia Hashimoto (EH) należy do kontrowersyjnych i słabo poznanych jednostek chorobowych. Patogeneza schorzenia pozostaje niejasna. Kryteria rozpoznania EH to obecność zaburzeń funkcji poznawczych, objawów deficytu neurologicznego i/lub zmian psychiatrycznych, wykluczenie innych przyczyn encefalopatii drogą diagnostyki różnicowej, stwierdzenie w surowicy krwi wysokich stężeń przeciwciał przeciwtarczycowych, przy wyrównanej zwykle funkcji tarczycy, oraz bardzo dobra odpowiedź na leczenie kortykosteroidami.
Słowa kluczowe: encefalopatia Hashimotoautoimmunizacyjne zapalenie tarczycySREAT
Referencje
- Carta MG, Hardoy MC, Carpiniello B, et al. A case control study on psychiatric disorders in Hashimoto disease and Euthyroid Goitre: not only depressive but also anxiety disorders are associated with thyroid autoimmunity. Clin Pract Epidemiol Ment Health. 2005; 10: 23.
- Chong JiY, Rowland LP, Utiger RD. Hashimoto encephalopathy: syndrome or myth? Arch Neurol. 2003; 60(2): 164–171.
- Dardano A, Bazzzichi L, Bombardieri S, et al. Symptoms in euthyroid Hashimoto's thyroiditis: is there a role for autoimmunity itself? Thyroid. 2012; 22(3): 334–335.
- Caturegli P, De Remigis A, Rose NR. Hashimoto thyroiditis: clinical and diagnostic criteria. Autoimmun Rev. 2014; 13(4-5): 391–397.
- Grani G, Carbotta G, Nesca A, et al. A comprehensive score to diagnose Hashimoto's thyroiditis: a proposal. Endocrine. 2015; 49(2): 361–365.
- Brain L, Jellinek EH, Ball K. Hashimoto's disease and encephalopathy. Lancet. 1966; 2(7462): 512–514.
- Laurent C, Capron J, Quillerou B, et al. Steroid-responsive encephalopathy associated with autoimmune thyroiditis (SREAT): Characteristics, treatment and outcome in 251 cases from the literature. Autoimmun Rev. 2016; 15(12): 1129–1133.
- Jamrozik Z, Janik P, Kiljański J, et al. Encefalopatia Hashimoto. Opis przypadku i przegląd literatury. Neurol Neurochir Pol. 2004; 38: 55–59.
- Tamagno G, Federspil G, Murialdo G. Clinical and diagnostic aspects of encephalopathy associated with autoimmune thyroid disease (or Hashimoto's encephalopathy). Intern Emerg Med. 2006; 1(1): 15–23.
- Mocellin R, Walterfang M, Velakoulis D. Hashimoto's encephalopathy : epidemiology, pathogenesis and management. CNS Drugs. 2007; 21(10): 799–811.
- Olmez I, Moses H, Sriram S, et al. Diagnostic and therapeutic aspects of Hashimoto's encephalopathy. J Neurol Sci. 2013; 331(1-2): 67–71.
- Payer J, Petrovic T, Lisy L, et al. Hashimoto encephalopathy: a rare intricate syndrome. Int J Endocrinol Metab. 2012; 10(2): 506–514.
- Gut P, Kosowicz J, Florczak J, et al. The incidence of the thyroid microsomal autoantibodies in Alzheimer disease. Endokrynol Pol. 2009; 60(4): 271–276.
- Ferracci F, Bertiato G, Moretto G. Hashimoto's encephalopathy: epidemiologic data and pathogenetic considerations. J Neurol Sci. 2004; 15(217): 165–168.
- Chou KM, Huang BY, Chen CH, et al. Correlation and presentation of thyroid functional status with thyroid autoantibodies in long-term follow-up of autoimmune thyroiditis: A study of 116 cases. J Formos Med Assoc. 2015; 114(11): 1039–1046.
- Ochi H, Horiuchi I, Araki N, et al. Proteomic analysis of human brain identifies alpha-enolase as a novel autoantigen in Hashimoto's encephalopathy. FEBS Lett. 2002; 528(1-3): 197–202.
- Leyhe T, Müssig K. Cognitive and affective dysfunctions in autoimmune thyroiditis. Brain Behav Immun. 2014; 41: 261–266.
- Caselli RJ, Boeve BF, Scheithauer BW, et al. Nonvasculitic autoimmune inflammatory meningoencephalitis (NAIM): a reversible form of encephalopathy. Neurology. 1999; 22(53): 1579–1581.
- Nolte KW, Unbehaun A, Sieker H, et al. Hashimoto encephalopathy: a brainstem vasculitis? Neurology. 2000; 8(54): 769–770.
- Tang Yi, Xing Yi, Lin MT, et al. Hashimoto's encephalopathy cases: Chinese experience. BMC Neurol. 2012; 24: 60.
- Hosoi Y, Kono S, Terada T, et al. Hashimoto's encephalopathy associated with an elevated intrathecal IgG4 level. J Neurol. 2013; 260(4): 1174–1176.
- Zhou JY, Xu B, Lopes J, et al. Hashimoto encephalopathy: literature review. Acta Neurol Scand. 2017; 135(3): 285–290.
- Tzakas P, Sit SW. Progressive impairment of cognition and motor function: Hashimoto encephalopathy. CMAJ. 2011; 183(8): E495–E497.
- Fatourechi V. Hashimoto's encephalopathy: myth or reality? An endocrinologist's perspective. Best Pract Res Clin Endocrinol Metab. 2005; 19(1): 53–66.
- Prat S, Jouan Y, Magnant J, et al. Hashimoto encephalopathy diagnosis after 40 years of a schizophrenia-like disorder. Schizophr Res. 2012; 139(1-3): 269–270.
- Casciato S, Di Bonaventura C, Lapenta L, et al. Recurrent partial seizures with ictal yawning as atypical presentation of Hashimoto's encephalopathy (steroid-responsive encephalopathy associated with autoimmune thyroiditis). Epilepsy Behav. 2011; 22(4): 799–803.
- Tsai MH, Lee LH, Chen SD, et al. Complex partial status epilepticus as a manifestation of Hashimoto's encephalopathy. Seizure. 2007; 16(8): 713–716.
- Cao NJ, Tselis AC, Li J, et al. A case of Hashimoto's encephalopathy: association with sensory ganglionopathy. J Neurol Sci. 2005; 238(1-2): 105–107.
- Kastrup O, Maschke M, Schlamann K, et al. Hashimoto encephalopathy and neuralgic amyotrophy--causal link or chance association? Eur Neurol. 2005; 53(2): 98–99.
- Sheng B, Lau KK, Li HoL, et al. A case of Hashimoto's encephalopathy with demyelinating peripheral neuropathy. Eur Neurol. 2005; 53(2): 84–85.
- Steczkowska M, Skowronek-Bała B, Wesołowska E. Neurofizjologiczna ocena dwóch pacjentek z encefalopatią Hashimoto. Przegl Lek. 2011; 11: 1154–1156.
- Muramatsu T, Hamano T, Shirafuji N, et al. [Hashimoto's encephalopathy presenting periodic synchronous discharge, as a differential diagnosis for Creutzfeldt-Jakob disease]. Rinsho Shinkeigaku. 2013; 53(9): 716–720.
- Devinsky O, Schein A, Najjar S. Epilepsy associated with systemic autoimmune disorders. Epilepsy Curr. 2013; 13(2): 62–68.
- Chen N, Qin W, Wei C, et al. Time course of Hashimoto's encephalopathy revealed by MRI: report of two cases. J Neurol Sci. 2011; 300(1-2): 169–172.
- Imperiale D, Guastamacchia G, Duca S, et al. Regression of white matter MRI abnormalities in nonvasculitic autoimmune inflammatory meningoencephalitis following intravenous immunoglobulin. Eur Neurol. 2007; 57(4): 244–245.
- Forchetti CM, Katsamakis G, Garron DC. Autoimmune thyroiditis and a rapidly progressive dementia: global hypoperfusion on SPECT scanning suggests a possible mechanism. Neurology. 1997; 49(2): 623–626.
